| Literature DB >> 31560151 |
Masaru Sakurai1,2, Masao Ishizaki1,2, Katsuyuki Miura3, Motoko Nakashima4, Yuko Morikawa5, Teruhiko Kido6, Yuchi Naruse7, Kazuhiro Nogawa8, Yasushi Suwazono8, Koji Nogawa8, Hideaki Nakagawa9.
Abstract
OBJECTIVES: The increasing number of working elderly people has enhanced the importance of workplace health promotion activities. We investigated the association between the health status of workers approximately 60 years of age and the risk of all-cause mortality after compulsory retirement in Japan.Entities:
Keywords: all-cause mortality; cohort study; compulsory retirement; elderly workers; risk factor
Mesh:
Year: 2019 PMID: 31560151 PMCID: PMC6970400 DOI: 10.1002/1348-9585.12088
Source DB: PubMed Journal: J Occup Health ISSN: 1341-9145 Impact factor: 2.708
Baseline characteristics of the study participants
| Total | Males | Females | |
|---|---|---|---|
| N | 2026 | 1299 | 727 |
| Age (y) | 59.6 ± 0.8 | 59.7 ± 0.7 | 59.4 ± 0.8 |
| Body mass index (kg/m2) | 23.1 ± 3.1 | 23.3 ± 2.9 | 22.8 ± 3.4 |
| Systolic blood pressure (mmHg) | 126.6 ± 18.7 | 127.5 ± 17.8 | 125.0 ± 20.1 |
| Diastolic blood pressure (mmHg) | 78.9 ± 11.7 | 80.5 ± 11.1 | 75.9 ± 12.0 |
| Triglycerides (mg/dL) | 95 (67‐136) | 102 (71‐150) | 83 (62‐112) |
| HDL‐cholesterol (mg/dL) | 60.8 ± 15.3 | 58.4 ± 15.3 | 65.1 ± 14.5 |
| LDL‐cholesterol (mg/dL) | 130.1 ± 13.2 | 124.0 ± 29.7 | 141.0 ± 30.9 |
| Fasting plasma glucose (mg/dL) | 102.7 ± 21.6 | 105.8 ± 24.2 | 97.3 ± 14.5 |
| HbA1c (NGSP, %) | 5.7 ± 0.8 | 5.8 ± 0.9 | 5.7 ± 0.6 |
| Medical treatment (%) | |||
| Hypertension | 15.5 | 17.0 | 12.8 |
| Dyslipidemia | 5.2 | 5.0 | 5.6 |
| Diabetes mellitus | 3.2 | 4.0 | 1.8 |
| Number of complicated metabolic abnormalities | |||
| 0 | 27.4 | 21.3 | 38.4 |
| 1 | 35.2 | 35.3 | 35.1 |
| 2 | 23.3 | 26.2 | 17.9 |
| 3 or 4 | 14.1 | 17.2 | 8.6 |
| Smoking status (%) | |||
| Nonsmoker | 56.3 | 32.9 | 98.1 |
| Ex‐smoker | 18.5 | 28.5 | 0.7 |
| Current smoker | 25.2 | 38.6 | 1.2 |
| Habitual alcohol drinking (%) | |||
| No | 54.3 | 37.7 | 83.9 |
| Yes | 45.7 | 62.3 | 16.1 |
| Habitual exercise (%) | |||
| No | 71.7 | 67.5 | 79.2 |
| Yes | 28.3 | 32.5 | 20.8 |
Data are n, means ± standard deviations, or medians (interquartile range).
Age‐ and sex‐adjusted hazard ratios (95% confidence interval) for all‐cause mortality among the study participants
| N | Number of mortalities | PY | Mortality rate (/1000 PY) | Adjusted HR (95% CI) | ||
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 1299 | 61 | 9773 | 6.2 | 3.41 | (1.73‐6.69) |
| Female | 727 | 10 | 5271 | 1.9 | 1.00 | (Reference) |
| Body mass index (kg/m2) | ||||||
| <18.5 | 105 | 10 | 750 | 13.3 | 3.84 | (1.91‐7.73) |
| 18.5‐24.9 | 1437 | 42 | 10 739 | 3.9 | 1.00 | (Reference) |
| ≥25.0 | 484 | 19 | 3555 | 5.3 | 1.33 | (0.77‐2.28) |
| Blood pressure (mmHg) | ||||||
| SBP <130, DBP <85 | 876 | 24 | 6379 | 3.8 | 1.00 | (Reference) |
| SBP 130‐139, DBP 80‐85 | 435 | 14 | 3314 | 4.2 | 0.95 | (0.49‐1.85) |
| SBP ≥140, DBP ≥85, or medical treatment | 715 | 33 | 5351 | 6.2 | 1.37 | (0.81‐2.33) |
| Dyslipidemia (high triglycerides and/or low HDL‐cholesterol) | ||||||
| No | 1524 | 48 | 11 406 | 4.2 | 1.00 | (Reference) |
| Yes | 502 | 23 | 3638 | 6.3 | 1.33 | (0.81‐2.20) |
| LDL‐cholesterol (mg/dL) | ||||||
| <140 | 1227 | 48 | 9118 | 5.3 | 1.00 | (Reference) |
| 140‐159 | 373 | 14 | 2792 | 5.0 | 1.11 | (0.61‐2.02) |
| ≥160 and/or medical treatment | 426 | 9 | 3134 | 2.9 | 0.68 | (0.33‐1.40) |
| FPG (mg/dL)/ HbA1c (%) | ||||||
| FPG <110, HbA1c <6.5 | 1568 | 46 | 11 760 | 3.9 | 1.00 | (Reference) |
| FPG 110‐125, HbA1c <6.5 | 219 | 12 | 1567 | 7.7 | 1.80 | (0.95‐3.41) |
| FPG ≥126, HbA1c ≥6.5, or medical treatment | 239 | 13 | 1717 | 7.6 | 1.77 | (0.95‐3.28) |
| Number of complicated metabolic abnormalities | ||||||
| 0 | 556 | 11 | 4081 | 2.7 | 1.00 | (Reference) |
| 1 | 713 | 25 | 5390 | 4.6 | 1.53 | (0.75‐3.12) |
| 2 | 471 | 20 | 3594 | 5.6 | 1.65 | (0.79‐3.47) |
| 3 or 4 | 286 | 15 | 1979 | 7.6 | 2.29 | (1.04‐5.02) |
| Smoking status | ||||||
| Nonsmoker | 1141 | 25 | 8582 | 2.9 | 1.00 | (Reference) |
| Ex‐smoker | 375 | 9 | 2732 | 3.3 | 0.90 | (0.44‐1.82) |
| Current smoker | 510 | 37 | 3730 | 9.9 | 2.63 | (1.51‐4.58) |
| Habitual alcohol drinking | ||||||
| No | 1100 | 29 | 7809 | 3.7 | 1.00 | (Reference) |
| Yes | 926 | 42 | 7235 | 5.8 | 0.96 | (0.57‐1.59) |
| Habitual exercise | ||||||
| No | 1453 | 44 | 10 268 | 4.3 | 1.00 | (Reference) |
| Yes | 573 | 27 | 4776 | 5.7 | 1.08 | (0.66‐1.76) |
Abbreviations: CI, confidence interval; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HR, hazard ratio; PY, person‐years; SBP, systolic blood pressure.
Obesity, high BP, dyslipidemia, or high FPG. Metabolic abnormalities were defined using the definition of metabolic syndrome for the Japanese population.
Multivariate‐adjusted hazard ratios (95% confidence interval) for all‐cause mortality among the study participants
|
Model 1 HR (95% CI) |
Model 2 HR (95% CI) | |||
|---|---|---|---|---|
| Sex | ||||
| Male | 2.19 | (0.98‐4.90) | 2.35 | (1.01‐5.47) |
| Female | 1.00 | (Reference) | 1.00 | (Reference) |
| Body mass index (kg/m2) | ||||
| <18.5 | 3.60 | (1.78‐7.25) | 3.72 | (1.83‐7.54) |
| 18.5‐24.9 | 1.00 | (Reference) | 1.00 | (Reference) |
| Smoking status | ||||
| Nonsmoker | 1.00 | (Reference) | 1.00 | (Reference) |
| Ex‐smoker | 0.80 | (0.35‐1.83) | 0.83 | (0.36‐1.88) |
| Current smoker | 2.15 | (1.18‐3.93) | 2.23 | (1.22‐4.09) |
| Number of complicated metabolic abnormalities | ||||
| 0 | 1.00 | (Reference) | 1.00 | (Reference) |
| 1 | 1.76 | (0.86‐3.62) | 1.76 | (0.86‐3.62) |
| 2 | 2.07 | (0.97‐4.40) | 2.09 | (0.98‐4.44) |
| 3 or 4 | 2.64 | (1.19‐5.88) | 2.67 | (1.20‐5.96) |
Abbreviations: CI, confidence interval; HR, hazard ratio.
Model 1: adjusted for all variables in the table; model 2: adjusted for the variables in model 1 as well as habitual alcohol drinking and habitual exercise.
Obesity, high blood pressure, dyslipidemia, or high fasting plasma glucose. Metabolic abnormalities were defined using the definition of metabolic syndrome for the Japanese population.
Hazard ratios (95% confidence interval) for all‐cause mortality in the sensitivity analysis
| N | Number of mortalities | PY | Mortality rate (/1000 PY) | Adjusted HR | ||
|---|---|---|---|---|---|---|
|
| ||||||
| Body mass index (kg/m2) | ||||||
| <18.5 | 52 | 9 | 391 | 23.0 | 4.36 | (2.06‐9.26) |
| 18.5‐24.9 | 918 | 35 | 6976 | 5.0 | 1.00 | (Reference) |
| ≥25.0 | 329 | 17 | 2406 | 7.1 | ‐ | |
| Smoking status | ||||||
| Nonsmoker | 428 | 15 | 3412 | 4.4 | 1.00 | (Reference) |
| Ex‐smoker | 370 | 9 | 2695 | 3.3 | 0.83 | (0.36‐1.91) |
| Current smoker | 501 | 37 | 3666 | 10.1 | 2.27 | (1.23‐4.22) |
| Number of complicated metabolic abnormalities | ||||||
| 0 | 277 | 6 | 2097 | 2.9 | 1.00 | (Reference) |
| 1 | 458 | 22 | 3481 | 6.3 | 2.60 | (1.04‐6.46) |
| 2 | 341 | 20 | 2642 | 7.6 | 3.40 | (1.35‐8.56) |
| 3 or 4 | 223 | 13 | 1553 | 8.4 | 3.62 | (1.36‐9.67) |
|
| ||||||
| Sex | ||||||
| Male | 1186 | 51 | 9546 | 5.3 | 2.14 | (0.83‐5.53) |
| Female | 633 | 8 | 5077 | 1.6 | 1.00 | (Reference) |
| Body mass index (kg/m2) | ||||||
| <18.5 | 93 | 9 | 725 | 12.4 | 4.16 | (1.95‐8.87) |
| 18.5‐24.9 | 1297 | 33 | 10 456 | 3.2 | 1.00 | (Reference) |
| ≥25.0 | 429 | 17 | 3443 | 4.9 | ‐ | |
| Smoking status | ||||||
| Nonsmoker | 1013 | 20 | 8323 | 2.4 | 1.00 | (Reference) |
| Ex‐smoker | 342 | 6 | 2664 | 2.3 | 0.73 | (0.27‐1.93) |
| Current smoker | 464 | 33 | 3638 | 9.1 | 2.48 | (1.27‐4.84) |
| Number of complicated metabolic abnormalities | ||||||
| 0 | 499 | 6 | 3965 | 1.5 | 1.00 | (Reference) |
| 1 | 648 | 22 | 5263 | 4.2 | 2.97 | (1.19‐7.42) |
| 2 | 420 | 16 | 3488 | 4.6 | 3.18 | (1.22‐8.26) |
| 3 or 4 | 252 | 15 | 1908 | 7.9 | 5.15 | (1.95‐13.6) |
Adjusted for the variables in model 2 (Table 3).
Obesity, high blood pressure, dyslipidemia, or high fasting plasma glucose. Metabolic abnormalities were defined using the definition of metabolic syndrome for the Japanese population.